ClinicalTrials.Veeva

Menu

Oral Iron Frequency for Childhood Restless Leg Syndrome/Periodic Limb Movement Disorder

Mayo Clinic logo

Mayo Clinic

Status and phase

Terminated
Phase 4

Conditions

Iron-deficiency
Sleep Disorder
Restless Legs Syndrome
Periodic Limb Movement Sleep Disorder

Treatments

Drug: Ferrous sulfate

Study type

Interventional

Funder types

Other

Identifiers

NCT04610827
20-007655

Details and patient eligibility

About

The purpose of this research study is to see if the level of serum ferritin differs based on how often oral iron (in the form of ferrous sulfate) is given to children with restless leg syndrome/periodic limb movement disorder.

Enrollment

6 patients

Sex

All

Ages

2 to 10 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Ferritin equal to or lower than 24 mcg/L drawn within the last 30 days.
  • Age 2 to 10 years.
  • Diagnosis of restless leg syndrome, periodic limb movement disorder, or sleep disturbance.

Exclusion criteria

  • Currently taking oral formulation of iron other than a multivitamin.
  • Untreated obstructive sleep apnea.
  • Gastrointestinal disorder, including gastroesophageal reflux disease and celiac disease.
  • Prior gastrointestinal surgery; e.g., gastrectomy, duodenal bypass, and presence of G-tube.
  • Use of H2 blocker, antacid, or proton pump inhibitor.
  • Inflammatory disorders, including juvenile idiopathic arthritis or inflammatory bowel disease.
  • Elevated CRP at time of initial ferritin or report of illness in past 4 weeks.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

6 participants in 3 patient groups

Ferrous sulfate daily
Active Comparator group
Description:
Subject will take 3 mg/kg oral iron in the morning
Treatment:
Drug: Ferrous sulfate
Ferrous sulfate twice daily
Active Comparator group
Description:
Subjects will take 1.5 mg/kg oral iron twice daily
Treatment:
Drug: Ferrous sulfate
Ferrous sulfate every other day
Active Comparator group
Description:
6 mg/kg oral iron every other day in the morning
Treatment:
Drug: Ferrous sulfate

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems